Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Mar;68(3):499-504.
doi: 10.1111/j.1476-5381.1980.tb14564.x.

Metabolism of [3H]-(+/-)-isoprenaline by isolated atria and coronary arteries of the kitten

Metabolism of [3H]-(+/-)-isoprenaline by isolated atria and coronary arteries of the kitten

E J Cornish et al. Br J Pharmacol. 1980 Mar.

Abstract

1 Isolated coronary arteries of the kitten accumulated more unchanged isoprenaline and metabolized more amine than atria following incubation for 1 to 20 min with [3H]-(+/-)-isoprenaline (25 ng/ml or 5 micrograms/ml). 2 Cortisol (10 or 80 microM), U-0521 (120 microM) and oxytetracycline (100 microM) all reduced metabolite formation. 3 Cortisol inhibited 'Iso InfluxMin' (cellular isoprenaline accumulation plus total metabolite production). In contrast, it increased, decreased or did not alter accumulation of unmetabolized isoprenaline, depending upon the experimental conditions. 4 Isoprenaline accumulation was increased in atria and reduced in coronary arteries by U-0521, while oxytetracycline reduced accumulation in coronary arteries at the high amine concentration. 5 It is concluded that in atria, cortisol inhibits metabolism and has differential effects on a number of extraneuronal compartments which accumulate isoprenaline. Both cortisol and U-0521 appear to be extraneuronal uptake inhibitors and inhibitors of catechol-O-methyltransferase in coronary arteries. Oxytetracycline may have effects additional to inhibition of isoprenaline binding to connective tissue fibres.

PubMed Disclaimer

References

    1. Br J Pharmacol. 1978 Jul;63(3):445-56 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1974;283(3):245-61 - PubMed
    1. Life Sci. 1965 Dec;4(24):2353-9 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1974;286(1):1-48 - PubMed
    1. J Neurochem. 1971 Jan;18(1):17-27 - PubMed

Publication types

LinkOut - more resources